XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
12 Months Ended
May 29, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Pre-Tax Compensation Expense and Related Tax Benefits Pre-tax compensation expense and the related income tax benefit for all types of stock-based programs were as follows for the periods indicated:
(In millions)May 29, 2021May 30, 2020June 1, 2019
Employee stock purchase program$0.4 $0.3 $0.3 
Stock option plans3.7 0.6 (0.4)
Restricted stock units4.1 3.9 4.6 
Performance share units0.8 (2.1)2.8 
Total$9.0 $2.7 $7.3 
Tax benefit$2.0 $0.5 $1.6 
Schedule of Fair Value of Employee Stock Options In determining these values, the following weighted-average assumptions were used for the options granted during the fiscal years indicated:
202120202019
Risk-free interest rates (1)
2.30-2.47% N/A 2.65-2.70%
Expected term of options (2)
3.8-4.1 years N/A 4.4 years
Expected volatility (3)
43-44% N/A 27 %
Dividend yield (4)
1.99 % N/A 2.18-2.33%
Weighted-average grant-date fair value of stock options:
Granted with exercise prices equal to the fair market value of the stock on the date of grant$6.10 N/A$8.05 
Granted with exercise prices greater than the fair market value of the stock on the date of grant$5.62 N/AN/A
(1) Represents term-matched, zero-coupon risk-free rate from the Treasury Constant Maturity yield curve, continuously compounded.
(2) Represents historical settlement data, using midpoint scenario with 1-year grant date filter assumption for outstanding options.
(3) The blended volatility approach was used. 90% term-matched historical volatility from daily stock prices and 10% percent weighted average implied volatility from the 90 days preceding the grant date.
(4) Represents the quarterly dividend divided by the three-month average stock price as of February 28, 2020.
Schedule of Stock Option Plan Transactions The following is a summary of the transactions under the Company's stock option plan:
Shares Under OptionWeighted-Average Exercise Prices
Aggregate Intrinsic Value
(in millions)
Weighted-Average Remaining Contractual Term (Years)
Outstanding at May 30, 2020361,416 $32.80 $0.2 5.8
     Granted at market1,409,792 $22.9 
Exercised(86,238)$30.81 
Forfeited or expired(11,598)$22.53 
Outstanding at May 29, 20211,673,372 $24.63  $38.8 8.56
Ending vested + expected to vest1,673,372 $24.63 $38.8 8.56
Exercisable at end of period230,462 $32.55 $3.5 5.35
Schedule of Restricted Stock Unit (RSU) Activity
The following is a summary of restricted stock unit transactions for the fiscal years indicated:
Share
Units
Weighted Average
Grant-Date
Fair Value
Aggregate Intrinsic Value (in millions)
Weighted-Average
Remaining Contractual
Term (Years)
Outstanding at May 30, 2020243,774 $37.02  $5.6  1.3
Granted307,652 $26.71   
Forfeited(6,955)$32.36   
Released(60,460)$33.98   
Outstanding at May 29, 2021484,011 $30.84  $23.1  1.4
Ending vested + expected to vest484,011 $30.84  $23.1  1.4
Schedule of Performance-based Stock Units (PSU) Activity
The following is a summary of performance share unit transactions for the fiscal years indicated:
Share
Units
Weighted Average Grant-Date Fair ValueAggregate Intrinsic Value (in millions)Weighted-Average Remaining Contractual Term (Years)
Outstanding at May 30, 2020384,537 $37.95 $8.9  1.3
Granted84,989 $37.21  
Forfeited(52,914)$24.76  
Released(48,553)$23.67 
Outstanding at May 29, 2021368,059 $41.54 $17.6  1.1
Ending vested + expected to vest368,059 $41.54 $17.6  1.1
Schedule of Director Share Based Compensation Under the plan, the Board members received the following shares or options in the fiscal years indicated:
202120202019
Shares of common stock3,013  7,769  10,185 
Shares through the deferred compensation program—  1,045  7,619